API Pharmaceutical Dasatinib 99% Anti-Cancer Dasatinib Raw Powder Dasatinib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Dasatinib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Dasatinib
• Name: Dasatinib Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti-Cancer
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 302962-49-8
• Mf: C22h26cln7o2s
• MW: 488.007
• Melting Point: 275-286°c
• Density: 1.408
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

API Pharmaceutical Dasatinib 99% Anti-Cancer Dasatinib Raw Powder Dasatinib

Product Description

Product Details

Product name	Dasatinib
Appearance	White powder
Cas number	302962-49-8
MF	C22H26ClN7O2S
MW	488.007

Dasatinib, also known as DASA tin IB, is a gray-white to yellow solid chemical. Dasatinib is an anti-tumor drug. The main clinical treatment is the chronic phase, accelerated phase and blast phase of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) that is resistant to or intolerant to imatinib mesylate. (Acute granular change and acute leaching change) Adult patients.

Application&Function

Dasatinib is used in all the stages of chronic myelogenous leukemia that have been treated, including imatinib mesylate/Gleevec (Imatinibmesylate/Gleevec) resistant or intolerable (chronic phase, accelerated phase, lymphoid cell blast phase and myeloid leukemia). Cell blast stage) adult patients. At the same time, the FDA has also approved dasatinib to treat Philadelphia chromosome-positive adult patients with acute lymphoblastic leukemia who are resistant or intolerant to other therapies through normal procedures.

Specification